Suchergebnisse - "Kuhn, Michael"

PubPharm (7)

1

Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia

enthalten in: Molecular cancer | 2023

von Tubío-Santamaría, N. | Jayavelu, A. | Schnoeder, T. | +23

2

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax

enthalten in: Haematologica | 2023

von Rausch, J. | Dzama, M. | Dolgikh, N. | +13

3

Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition

enthalten in: Blood | 2020

von Dzama, M. | Steiner, M. | Rausch, J. | +14

CommentIn: Blood. 2020 Nov 19;136(21):2369-2370. - PMID 33211832

4

Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia

enthalten in: Cancer discovery | 2016

von Kühn, M. | Song, E. | Feng, Z. | +13

CommentIn: Cancer Discov. 2016 Oct;6(10 ):1087-1089. - PMID 27698101

5

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition

enthalten in: Haematologica | 2015

von Kühn, M. | Hadler, M. | Daigle, S. | +8

6

Designed to kill : novel menin-MLL inhibitors target MLL-rearranged leukemia

enthalten in: Cancer cell | 2015

von Kühn, M. | Armstrong, S.

CommentOn: Cancer Cell. 2015 Apr 13;27(4):589-602. - PMID 25817203

7

Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias : a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Gröschel, S. | Schlenk, R. | Engelmann, J. | +26

1
[1]